Thursday, August 25, 2022

Merck's Carlow, Ireland Immuno-Oncology Production Facilities Expanding: 700 New Hires


This is good news for my talented bio-science cousins on the Emerald Isle.

The existing Carlow array of facilities employs about 530, and this will add more than 100 jobs in County Carlow, immediately -- more as it comes fully on line by 2025. Here's the bit, from the Irish newspapers:

. . .Merck says that the site, which originally opened in 2008 and is the firm’s first vaccine facility outside of the US, will begin construction and hiring for positions immediately. The company aims to begin production operations in 2025.

Once operational, Merck said the roles will include operations, quality, engineering, supply chain, and technical support. Furthermore, as well as the 100 permanent positions created through the expansion, 700 roles will be made during the building process.

“The construction of this additional facility will only add to our ability to be able to offer current and future employees a truly unique experience across our sites in Ireland, offering an opportunity to experience all elements of pharmaceutical and biotech manufacturing within Ireland while pursuing a purposeful career that helps make a difference to patients the world over,” said Mairead McCaul, managing director of MSD Ireland (Human Health) and head of MSD Ireland country leadership team. . . .


Now you know -- grinning at the fine people Merck employs, world-wide -- but I am especially proud of my cousins, being part of their diaspora, now generations on. Grinning -- from running taverns on the Isle, to mining in the high Rockies of my youth. . . now to the cutting edge of human bio-science.

नमस्ते

No comments: